EverHint – SMA 20/50 Crossover – Top 3 Buy and Top 5 Sell Signals for Sep 14, 2026
Excerpt: 8 signals (from 9 total). Financial Services leads (5). price range $19-$515.
What This Signal Is
Detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50). Uses two SMAs, making it more stable and less prone to false signals compared to EMA-based strategies. Well-suited for identifying medium-term trend changes with higher reliability.
Entry Criteria:
- Buy: SMA20 crosses above SMA50
- Sell: SMA20 crosses below SMA50
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 2-6 weeks | Risk level: Medium
Market Context
The broad equity market is experiencing modest but notable selling pressure on September 14, 2026, with all three major indices posting declines and the Nasdaq leading losses at -0.56%. This mild risk-off tone suggests that momentum-based strategies like the 20/50-day simple moving average crossover may face some near-term headwinds, as trending conditions can weaken when broad market participation softens. That said, the declines remain contained, meaning established intermediate-term trends are unlikely to be severely disrupted in a single session.
The more significant development is the VIX jumping nearly 8% to 17.10, signaling a meaningful uptick in implied volatility. While 17 remains within a historically moderate range, the sharp single-day spike warrants caution — elevated volatility tends to produce wider intraday price swings, which can trigger false crossover signals or cause entries and exits to occur at less favorable prices. Traders relying on SMA-based signals should factor in wider price ranges when sizing positions and setting stop levels.
The concentration of signals in the Financial Services sector is worth noting in this context. Financials are sensitive to interest rate expectations and broader risk sentiment, meaning a volatility-driven pullback could create short-term noise around otherwise valid trend signals. However, sector rotation into Financials during periods of moderate volatility is not uncommon, as the sector can attract defensive capital seeking yield-oriented positioning. The nine total signals generated suggest selective, rather than broad-based, trend confirmation — a prudent reflection of the current mixed market environment.
🟢 Buy Signals (3 of 3 total)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | BRK-B | Berkshire Hathaway Inc. | Financial Services | $514.95 | $1110.7B |
| 2 | CNC | Centene Corp. | Healthcare | $69.38 | $34.3B |
| 3 | ICLR | ICON Public Limited Co... | Healthcare | $168.93 | $12.9B |
🔴 Sell Signals (5 of 6 total)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | ALL | The Allstate Corporation | Financial Services | $258.46 | $66.5B |
| 2 | HQY | HealthEquity, Inc. | Healthcare | $96.04 | $8.0B |
| 3 | MFC | Manulife Financial Cor... | Financial Services | $43.55 | $72.7B |
| 4 | RLAY | Relay Therapeutics, Inc. | Healthcare | $19.06 | $4.2B |
| 5 | UBSI | United Bankshares, Inc. | Financial Services | $47.69 | $6.6B |
Field Notes
Sector concentration: Financial Services (5), Healthcare (4)
Data coverage: 0.0% insider (7d), 0.0% congressional (30d), 0.0% earnings, 33.3% news (7d)
Peer Analysis
RLAY (Relay Therapeutics, Inc.): Leads 5 peers: SNDX ($18.35), ORIC ($12.65), AMLX ($33.64), INBX ($110.47), UPB ($5.81)
MFC (Manulife Financial Corporation): Leads 5 peers: BNS ($93.43), CM ($114.17), LNC ($44.04), MET ($97.75), PRU ($119.50)
ICLR (ICON Public Limited Company): Leads 5 peers: GH ($167.84), MEDP ($595.41), QGEN ($41.88), UHS ($173.25), RVTY ($128.49)
ALL (The Allstate Corporation): Leads 5 peers: AFL ($116.99), CB ($341.85), CINF ($172.02), HIG ($137.59), PGR ($221.02)
Recent Headlines
ALL (The Allstate Corporation)
- Allstate (ALL) Gains As Market Dips: What You Should Know
- Higher Rates Are a Gift to These 3 Insurance Dividend Stocks
BRK-B (Berkshire Hathaway Inc.)
- Berkshire Hathaway Stock Has Gone Almost Nowhere in a Year. Should You Buy It Right Now?
- Berkshire Hathaway: A Great Investment In A Complex Market
- Berkshire Hathaway (BRKB) Stock Is the Financial Stock I'd Still Want to Own in 2036, and Not Because of Warren Buffett
- Berkshire Hathaway Stock Is Trailing the S&P 500 by About 10 Points This Year. History Says That Usually Doesn't Last.
- Warren Buffett Made Apple Berkshire Hathaway's Single Largest Stock Position: $10,000 Invested 10 Years Ago Would Be Worth Roughly $122,400 Today
- Berkshire Hathaway Has Nearly 14% of Its $359 Billion Portfolio Invested in This Winning Stock That's Doubled in 5 Years
- Berkshire Hathaway Has Paid Exactly 1 Dividend Since 1965. Here's Where the Cash Goes Instead.
CNC (Centene Corp.)
- Centene Corp stock hits 52-week high at 69.36 USD
Vlad's Take
Today's signals: Strong sector concentration in Financial Services (5 signals) suggests sector-specific rotation.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 If you found this useful, a quick like, share, or subscribe keeps EverHint moving forward.